Buy Like Buffett
Watchlist

Flagship explainer

How NEPHROS, INC. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$18.8M · 100%Cost of revenue$7.2M · 38%Gross profit$11.6M · 62%Operating income$1.1M · 6%Income before tax$1.2M · 6%Income tax$12000 · 0%Net income$1.2M · 6%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$18.8M100%
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-009848 · filed Mar 12, 2026
Cost of revenue$7.2M38%
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-009848 · filed Mar 12, 2026
$11.6M62%
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-009848 · filed Mar 12, 2026
$1.1M6%
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-009848 · filed Mar 12, 2026
Income before tax$1.2M6%
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-009848 · filed Mar 12, 2026
Income tax$120000%
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-009848 · filed Mar 12, 2026
$1.2M6%
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-009848 · filed Mar 12, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0001493152-26-009848 · filed Mar 12, 2026
· event Dec 31, 2025 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full NEPHROS, INC. analysis at Buy Like Buffett